BOARD OF DIRECTORS

The Board of Directors (BoD) runs the general affairs and represents the VPH Institute in all circumstances. Its main duty is to drive the Institute policy, setting the agendas, proposing specific actions and approving the annual business plan.

The current Board of Directors is composed by the representatives of the supporting members, eleven prestigious organisations that excel worldwide for their research quality and their focus on in silico medicine.

Executive Director

Prof.Liesbet Geris

Universities of Liège and KUL – Leuven (Belgium)

Director

Rossana Alessandrello

Agència de Qualitat i Avaluació Sanitàries de Catalunya - AQuAS (Spain)
Director

Prof.Ilse Jonkers

KULeuven (Belgium)
Director

Dr. Irene Vignon-Clementel

Inria (France)
Director

Prof. Reinhard Schneider

Luxembourg Centre for Systems Biomedicine (Luxembourg)
Director

Prof.Leif Rune Hellevik

Norwegian University of Science and Technology (Norway)
Director

Prof.Alfons Hoekstra

University of Amsterdam (Netherlands)
Director

Prof.Merryn Tawhai

University of Auckland (New Zealand)
Director

Prof.Marco Viceconti

University of Bologna (Italy)
Director

Dr.Claudio Capelli

UCL Institute of Cardiovascular Science / Great Ormond Street Hospital for Children (United Kingdom)
Director

Prof.Damien Lacroix

University of Sheffield (United Kingdom)
Director

Prof.Francesco Pappalardo

University of Catania (Italy)